UNSPSC 51152059: Hexcarbacholine bromide

This classification denotes a muscle relaxant with the molecular formula C18H40N4O4.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NM87THP11P, chemically known as n,n,n,n,n,n-hexamethyl-4,13-dioxo-3,14-dioxa-5,12-diazahexadecamethylendiammonium dibromid but more generally known as hexcarbacholine bromide, which bears US NIH Compound Identifier 71495. European Medicines Agency schedules Hexcarbacholine bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08034MIG.

UNSPSC 51152059 Hexcarbacholine bromide is a Commodity code that shows minimal alignment with actual state and local procurement activity in the available record. The recent opportunity tagged under this code — Seminole County, Florida's IFB for naloxone and drug deactivation systems — does not match the nominal chemical compound scope. Seminole County sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding for community health initiatives, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The work is not pharmaceutical chemical supply in the sense the code name suggests, but rather acquisition of finished medical countermeasure products and harm-reduction equipment.

The geographic and issuing-body data supporting this code is too thin to characterize meaningfully. Seminole County, Florida represents the only recent opportunity in the block. The IFB closed on July 26, 2023, with electronic bid submission required through the county's e-Procurement Portal, and included standard compliance requirements such as drug-free workplace certification, E-Verify confirmation, and insurance coverage (workers' compensation, commercial general liability, professional liability). The contract offered an initial two-year term with an optional one-year renewal and a three-month probationary termination window. No explicit set-aside designations were specified. Given the mismatch between the code's nominal scope and the actual solicitation, firms pursuing state and local opportunities in naloxone or drug deactivation equipment should verify code assignment before relying on this Commodity classification for pipeline development.